{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:17:31Z","timestamp":1790864251046,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1719-4","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:50:22Z","timestamp":1538563822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-8703","authenticated-orcid":false,"given":"Paola","family":"Di Benedetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onorina","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Panzera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Di Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Triolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"1719_CR1","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/eji.200939877","volume":"40","author":"S Lax","year":"2010","unstructured":"Lax S, Hardie D, Wilson A, Douglas M, Anderson G, Huso D, et al. The pericyte and stromal marker CD248 (endosialin) is required for efficient lymph node expansion. Eur J Immunol. 2010;40:1884\u20139.","journal-title":"Eur J Immunol"},{"key":"1719_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mvr.2008.07.008","volume":"76","author":"RG Bagley","year":"2008","unstructured":"Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, et al. Endosialin\/TEM1\/CD248 is a pericyte marker of embryonic and tumor neovascularisation. Microvasc Res. 2008;76:180\u20138.","journal-title":"Microvasc Res"},{"key":"1719_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ki.2011.103","volume":"80","author":"SW Smith","year":"2011","unstructured":"Smith SW, Eardley KS, Croft A, Nwosu J, Howie AJ, Cockwell P, et al. CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int. 2011;80:199\u2013207.","journal-title":"Kidney Int"},{"key":"1719_CR4","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1002\/art.27701","volume":"62","author":"M Maia","year":"2010","unstructured":"Maia M, de Vriese A, Janssens T, Moons M, van Landuyt K, Tavernier J, et al. CD248 and its cytoplasmic domain: a therapeutic target for arthritis. Arthritis Rheum. 2010;62:3595\u2013606.","journal-title":"Arthritis Rheum"},{"key":"1719_CR5","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.1073\/pnas.89.22.10832","volume":"89","author":"WJ Rettig","year":"1992","unstructured":"Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A. 1992;89:10832\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1719_CR6","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1158\/1078-0432.CCR-08-0499","volume":"14","author":"C Rouleau","year":"2008","unstructured":"Rouleau C, Curiel M, Weber W, Smale R, Kurtzberg L, Mascarello J, et al. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Clin Cancer Res. 2008;14:7223\u201336.","journal-title":"Clin Cancer Res"},{"key":"1719_CR7","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/jnen\/63.12.1274","volume":"63","author":"J Brady","year":"2004","unstructured":"Brady J, Neal J, Sadakar N, Gasque P. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. J Neuropathol Exp Neurol. 2004;63:2374\u201383.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1719_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000438754","volume":"131","author":"SW Smith","year":"2015","unstructured":"Smith SW, Croft AP, Morris HL, Naylor AJ, Huso DL, Isacke CM, Savage CO, Buckley CD. Genetic deletion of the stromal cell marker CD248 (endosialin) protects against the development of renal fibrosis. Nephron. 2015;131:265\u201377.","journal-title":"Nephron"},{"key":"1719_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000440890","volume":"131","author":"M Chang-Panesso","year":"2015","unstructured":"Chang-Panesso M, Humphreys BD. CD248\/endosialin: a novel pericyte target in renal fibrosis. Nephron. 2015;131:262\u20134.","journal-title":"Nephron"},{"key":"1719_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2407-11-162","volume":"11","author":"M Maia","year":"2011","unstructured":"Maia M, DeVriese A, Janssens T, Moons M, Lories RJ, Tavernier J, et al. CD248 facilitates tumor growth via its cytoplasmic domain. BMC Cancer. 2011;11:162.","journal-title":"BMC Cancer"},{"key":"1719_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/ijo.30.2.305","volume":"30","author":"BA Teicher","year":"2007","unstructured":"Teicher BA. Newer vascular targets: endosialin (review). Int J Oncol. 2007;30:305\u201312.","journal-title":"Int J Oncol"},{"key":"1719_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2174\/138945012799424615","volume":"13","author":"Y Valdez","year":"2012","unstructured":"Valdez Y, Maia M, Conway EM. CD248: reviewing its role in health and disease. Curr Drug Targets. 2012;13:432\u20139.","journal-title":"Curr Drug Targets"},{"key":"1719_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/1078-0432.CCR-14-1829","volume":"21","author":"LA Diaz","year":"2015","unstructured":"Diaz LA, Coughlin CM, Weil SC, Fishel J, Gounder MM, Lawrence S, et al. A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors. Clin Cancer Res. 2015;21:1281\u20138.","journal-title":"Clin Cancer Res"},{"key":"1719_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ncprheum0115","volume":"2","author":"CP Denton","year":"2006","unstructured":"Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2:134\u201344.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1719_CR15","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989\u20132003.","journal-title":"N Engl J Med"},{"key":"1719_CR16","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3899\/jrheum.150088","volume":"42","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Capece D, Zazzeroni F, Liakouli V, et al. The endothelial-mesenchymal transition in SSc is induced by the synergistic effect of ET-1 and TGF-\u03b2 and may be blocked by macitentan, a new dual ET-1 receptor antagonist. J Rheumatol. 2015;42:1808\u201316.","journal-title":"J Rheumatol"},{"key":"1719_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","volume":"16","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Campese AF, Liakouli V, Carubbi F, et al. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther. 2014;16:442.","journal-title":"Arthritis Res Ther"},{"key":"1719_CR18","first-page":"835948","volume":"23","author":"SA Jimenez","year":"2013","unstructured":"Jimenez SA. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013;23:835948.","journal-title":"ISRN Rheumatol"},{"key":"1719_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/gutjnl-2014-308325","volume":"65","author":"A Wilhelm","year":"2016","unstructured":"Wilhelm A, Aldridge V, Haldar D, Naylor AJ, Weston CJ, Hedegaard D, et al. CD248\/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism. Gut. 2016;65:1175\u201385.","journal-title":"Gut"},{"key":"1719_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.5114\/aoms.2016.60970","volume":"12","author":"P Cipriani","year":"2016","unstructured":"Cipriani P, Di Benedetto P, Dietrich H, Ruscitti P, Liakouli V, Carubbi F, Pantano I, Berardicurti O, Sgonc R, Giacomelli R. Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis. Arch Med Sci. 2016;12:828\u201343.","journal-title":"Arch Med Sci"},{"key":"1719_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/157339710793205611","volume":"6","author":"SA Jim\u00e9nez","year":"2010","unstructured":"Jim\u00e9nez SA, Castro SV, Piera-Vel\u00e1zquez S. Role of growth factors in the pathogenesis of tissue fibrosis in systemic sclerosis. Curr Rheumatol Rev. 2010;6:283\u201394.","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"1719_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41467-017-01168-1","volume":"8","author":"C Sacchetti","year":"2017","unstructured":"Sacchetti C, Bai Y, Stanford SM, Di Benedetto P, Cipriani P, Santelli E, et al. PTP4A1 promotes TGF\u03b2 signaling and fibrosis in systemic sclerosis. Nat Commun. 2017;8(1):1060.","journal-title":"Nat Commun"},{"key":"1719_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/cei.12111","volume":"173","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Di Benedetto P, Liakouli V, Del Papa B, Di Padova M, Di Ianni M, Marrelli A, Alesse E, Giacomelli R. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. Clin Exp Immunol. 2013;173:195\u2013206.","journal-title":"Clin Exp Immunol"},{"key":"1719_CR24","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","volume":"10","author":"P Cipriani","year":"2011","unstructured":"Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev. 2011;10:641\u20136.","journal-title":"Autoimmun Rev"},{"key":"1719_CR25","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3899\/jrheum.150996","volume":"43","author":"P Cipriani","year":"2016","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Liakouli V, Berardicurti O, Carubbi F, et al. Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis. J Rheumatol. 2016;43:1340\u20139.","journal-title":"J Rheumatol"},{"key":"1719_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","volume":"16","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Marrelli A, Di Benedetto P, Liakouli V, Carubbi F, Ruscitti P, et al. Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis. 2013;16:595\u2013607.","journal-title":"Angiogenesis"},{"key":"1719_CR27","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"1719_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"1719_CR29","first-page":"367","volume":"4","author":"MB Kahaleh","year":"1986","unstructured":"Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986;4:367\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1719_CR30","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902\u201312.","journal-title":"Arthritis Rheum"},{"key":"1719_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12890-016-0211-7","volume":"16","author":"D Bartis","year":"2016","unstructured":"Bartis D, Crowley LE, D\u2019Souza VK, Borthwick L, Fisher AJ, Croft AP, et al. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis. BMC Pulm Med. 2016;16:51.","journal-title":"BMC Pulm Med"},{"issue":"5-6","key":"1719_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.gep.2011.03.001","volume":"11","author":"Hsiang-Po Huang","year":"2011","unstructured":"Huang HP, Hong CL, Kao CY, Lin SW, Lin SR, Wu HL et al.\u00a0Gene targeting and expression analysis of mouse Tem1\/endosialin using a lacZ reporter.\u00a0Gene Expr Patterns. 2011;11:316\u201326.","journal-title":"Gene Expression Patterns"},{"key":"1719_CR33","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1074\/jbc.M009604200","volume":"276","author":"S Christian","year":"2001","unstructured":"Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi HP, Garin-Chesa P, et al. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem. 2001;276:7408\u201314.","journal-title":"J Biol Chem"},{"key":"1719_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-016-0359-3","volume":"7","author":"DA Moraes","year":"2016","unstructured":"Moraes DA, Sibov TT, Pavon LF, Alvim PQ, Bonadio RS, Da Silva JR, et al. A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells. Stem Cell Res Ther. 2016;7:97.","journal-title":"Stem Cell Res Ther"},{"key":"1719_CR35","doi-asserted-by":"crossref","unstructured":"Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells. Am J Pathol. 2008;172(2):486\u201394.","DOI":"10.2353\/ajpath.2008.070623"},{"key":"1719_CR36","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.febslet.2005.03.071","volume":"579","author":"JR MacFadyen","year":"2005","unstructured":"MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 2005;579:2569\u201375.","journal-title":"FEBS Lett"},{"key":"1719_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3892\/ijo_00000187","volume":"34","author":"RG Bagley","year":"2009","unstructured":"Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol. 2009;34:619\u201327.","journal-title":"Int J Oncol"},{"key":"1719_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/modpathol.3801006","volume":"21","author":"N Simonavicius","year":"2008","unstructured":"Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol. 2008;21:308\u201315.","journal-title":"Mod Pathol"},{"key":"1719_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66:754\u201363.","journal-title":"Ann Rheum Dis"},{"key":"1719_CR40","first-page":"2454","volume":"28","author":"S Jacobsen","year":"2001","unstructured":"Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol. 2001;28:2454\u20139.","journal-title":"J Rheumatol"},{"key":"1719_CR41","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1378\/chest.116.3.715","volume":"116","author":"E Diot","year":"1999","unstructured":"Diot E, Giraudeau B, Diot P, Degenne D, Ritz L, Guilmot JL, et al. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest. 1999;116:715\u201320.","journal-title":"Chest"},{"key":"1719_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Marini FC, Krause DS, Deans RJ, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"1719_CR43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393\u20135.","journal-title":"Cytotherapy"},{"key":"1719_CR44","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1158\/1535-7163.MCT-08-0050","volume":"7","author":"RG Bagley","year":"2008","unstructured":"Bagley RG, Rouleau C, St Martin T, Boutin P, Weber W, Ruzek M, et al. Human endothelial precursor cells express tumor endothelial marker 1\/endosialin\/CD248. Mol Cancer Ther. 2008;7:2536\u201346.","journal-title":"Mol Cancer Ther"},{"key":"1719_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00005072-199505000-00003","volume":"54","author":"P Wesseling","year":"1995","unstructured":"Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes\/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. J Neuropathol Exp Neurol. 1995;54:304\u201310.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1719_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/1471-2407-9-417","volume":"9","author":"EB Carson-Walter","year":"2009","unstructured":"Carson-Walter EB, Winans BN, Whiteman MC, Liu Y, Jarvela S, Haapasalo H, et al. Characterization of TEM1\/endosialin in human and murine brain tumors. BMC Cancer. 2009;9:417.","journal-title":"BMC Cancer"},{"key":"1719_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301\u201313.","journal-title":"Cell Stem Cell"},{"key":"1719_CR48","first-page":"183","volume":"63","author":"S Kontsekova","year":"2016","unstructured":"Kontsekova S, Polcicova K, Takacova M, Pastorekova S. Endosialin: molecular and functional links to tumor angiogenesis. Neoplasma. 2016;63:183\u201392.","journal-title":"Neoplasma"},{"key":"1719_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2407-14-113","volume":"14","author":"S Suresh Babu","year":"2014","unstructured":"Suresh Babu S, Valdez Y, Xu A, O\u2019Byrne AM, Calvo F, Lei V, et al. TGF\u03b2-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells. BMC Cancer. 2014;14:113.","journal-title":"BMC Cancer"},{"key":"1719_CR50","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1074\/jbc.M706651200","volume":"283","author":"S Kennard","year":"2008","unstructured":"Kennard S, Liu H, Lilly B. Transforming growth factor-\u03b2 (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem. 2008;283:1324\u201333.","journal-title":"J Biol Chem"},{"key":"1719_CR51","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","volume":"40","author":"LA Murray","year":"2008","unstructured":"Murray LA, Argentieri RL, Farrell FX, Bracht M, Sheng H, Whitaker B, et al. Hyper-responsiveness of IPF\/UIP fibroblasts: interplay between TGF\u03b21, IL-13 and CCL2. Int J Biochem Cell Biol. 2008;40:2174\u201382.","journal-title":"Int J Biochem Cell Biol"},{"key":"1719_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13075-015-0754-7","volume":"17","author":"P Cipriani","year":"2015","unstructured":"Cipriani P, Di Benedetto P, Ruscitti P, Verzella D, Fischietti M, Zazzeroni F, et al. Macitentan inhibits the transforming growth factor-\u03b2 profibrotic action, blocking the signaling mediated by the ETR\/T\u03b2RI complex in systemic sclerosis dermal fibroblasts. Arthritis Res Ther. 2015;17:247.","journal-title":"Arthritis Res Ther"},{"key":"1719_CR53","doi-asserted-by":"crossref","first-page":"25429","DOI":"10.18632\/oncotarget.4559","volume":"22","author":"K Rybinski","year":"2015","unstructured":"Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y. Targeting endosialin\/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature. Oncotarget. 2015;22:25429\u201340.","journal-title":"Oncotarget"},{"key":"1719_CR54","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4161\/cbt.9.11.11731","volume":"9","author":"B Tomkowicz","year":"2010","unstructured":"Tomkowicz B, Rybinski K, Sebeck D, Sass P, Nicolaides NC, Grasso L, et al. Endosialin\/TEM-1\/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer Biol Ther. 2010;9:908\u201315.","journal-title":"Cancer Biol Ther"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1719-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1719-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:56:08Z","timestamp":1761108968000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1719-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1719-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiments reported in this article comply with the current ethical standard laws of Italy. All patients gave fully informed written consent approved by the institutional ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"223"}}